NEWS & More

THE LATEST NEWS AND EVENTS

Aitia’s CEO Wants You to Use AI to Do More than Designing Drugs Against Known Validated Targets
Apr 24, 2024

Aitia’s CEO Wants You to Use AI to Do More than Designing Drugs Against Known Validated Targets

Insights by Servier
Mar 18, 2024

Digital Twins: When AI drives progress for the pharmaceutical industry

How Digital Twins are Transforming Medicine
Mar 12, 2024

How Digital Twins are Transforming Medicine

Feb 29, 2024

HDTC Poster | Prediction of HD-related clinical outcome progression and imaging markers using AI-based Digital Twins

WSJ Health Forum
Jan 30, 2024

Meet us at WSJ Health Forum

At health care’s biggest investor conference, AI’s high hopes collided with skepticism - STAT article
Jan 18, 2024

Unveiling the AI Dominance in Biopharma: STAT Post JPM Conference Insights

Servier Will Apply Aitia's Digital Twins to Parkinson’s Drug
Jan 08, 2024

Servier Will Apply Aitia’s Gemini Digital Twins to Parkinson’s Drug

Aitia Servier Partnership 300x300 1
Nov 29, 2023

Partner of Choice: Aitia and Servier Revolutionize the Landscape of Pancreatic Cancer Treatment

CRL
Nov 16, 2023

Charles River and Aitia Join Forces to Harness AI and Gemini Digital Twins in Advancing Neurodegenerative and Oncology Research

Nov 13, 2023

NfS Poster | Genes regulating cytoskeleton organization identified as neuro-common drivers of blood NfL change rate and disease-specific clinical progression in AI driven Digital Twins